Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sederma
Le Perray-en-Yvelines, Île-de-France / Yvelines, Francecrodabeauty.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sederma develops and manufactures bioactive ingredients—primarily peptides and plant cell culture derivatives—for the global cosmetics industry. Its best-known product line includes Matrixyl peptides for anti-ageing applications. The company uses advanced biotechnology including synthetic biology to create sustainable cosmetic actives with proven efficacy through in vitro/ex vivo/in vivo testing. It does not develop pharmaceutical drugs or therapeutics.
- Therapeutic areas
- Dermatology
- Modalities
- PeptidesProteinsPlant cell culture-derived ingredientsSmall molecule cosmetic activesFermentation-derived ingredientsSynthetic biology-based moleculesBotanical extracts
- Industry
- Non-Drug Biotech
02
Partnerships
Alganelle (synthetic biology/microalgae partnership)
Beyond the preview
Go deeper on Sederma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sederma.